Pathogenesis of mouse hepatitis virus-induced demyelination

Journal of NeuroVirology

Volumn 2, Issue 6, 1996, Pages 361-376

  Houtman, Jacqueline J ^a   Fleming, John O ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Coronavirus; Immunopathology; Multiple sclerosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE PROTEIN; VIRUS ANTIBODY;

ANIMAL DISEASE; AUTOIMMUNITY; DEMYELINATION; ENCEPHALITIS; IMMUNE STATUS; IMMUNOPATHOLOGY; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS RESISTANCE;

EID: 0030461287     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146902     Document Type: Review

References (186)

1. Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Fleming JO, Baker SC (1995). Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Asanaka M, Lai MMC (1993). Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology 197: 732-741.
3. Bailey OT, Pappenheimer AM, Cheever FS, Daniels JB (1949). A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. J Exp Med 90: 195-212.
4. Banner LR, Keck GK, Lai MMC (1990). A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175: 548-555.
5. Barthold SW, Smith AL (1984). Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Arch Virol 81: 103-112.
6. Barthold SW (1988). Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta Neuropatholog 76: 502-506.
7. Barthold SW, Smith AL (1992). Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Arch Virol 122: 35-44.
8. d-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J Virol 67: 7041-7049.
9. Bos EC, Heijnen L, Luytjes W, Spaan WJM. (1995). Mutational analysis of the murine coronavirus spike protein: Effect on cell-to-cell fusion. Virology 214: 453-463.
10. Boyle JF, Weismiller DG, Holmes KV (1987). Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J Virol 61: 185-189.
11. Brosnan CF, Selmaj K, Raine CS (1988). Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87-94.
12. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984). Murine hepatitis virus-4 (Strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132: 261-270.
13. Bürge T, Griot C, Vandevelde M, Peterhans E (1989). Antiviral antibodies stimulate production of reactive oxygen species in cultured canine brain cells infected with canine distemper visus. J Virol 63: 2790-2797.
14. Buschman E, Skamene E (1995). Genetic resistance to coronavirus infection. A review. In: Talbot PJ, Levy GA (eds), Corona- and Related Viruses. Plenum Press: New York, pp 1-11.
15. Castro RF, Evans GD, Jaszewski A, Perlman S (1994). Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology 200: 733-743.
16. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 69: 8127-8131.
17. Cheever FS, Daniels JB, Peppenheimer AM, Bailey OT (1949). A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. I. Isolation and biological properties of the virus. J Exp Med 90: 181-194.
18. Clatch RJ, Lipton HL, Miller SD (1996). Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J Immunol 136: 920-927.
19. Compton SR, Stephensen CB, Snyder SW, Weismiller DG, Holmes KV (1992). Coronavirus species specificity: Murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein. J Virol 66: 7420-7428.
20. Compton SR, Barthold SW, Smith AL (1993). The cellular and molecular pathogenesis of corohaviruses. Lab Anim Sci 43: 15-28.
21. Cook-Mills JM, Munshi HG, Perlman RL, Chambers DA (1992). Mouse hepatitis virus infection suppresses modulation of mouse spleen T-cell activation. Immunology 75: 542-545.
22. Correale J, Li S, Weiner LP, Gilmore W (1995). Effect of persistent mouse hepatitis virus infection on MHC Class I expression in murine astrocytes. J Neurosci Res 40: 10-21.
23. Cray C, Mateo MO, Altman NH (1993). In vitro and long-term in vivo immune dysfunction after infection of BALB/c mice with mouse hepatitis virus strain A59. Lab Anim Sci 43: 169-174.
24. Dal Canto MC, Rabinowitz SG (1981). Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol 11: 109-127.
25. Dal Canto MC (1990). Experimental models of virus-induced demyelination. In: Cook SD (ed), Handbook of Multiple Sclerosis. Marcel Dekker, Inc: New York, pp 63-100.
26. Dales S (1995). Factors controlling coronavirus infections and disease of the central nervous system. A review. In: Talbot PJ, Levy GA (eds). Corona- and Related Viruses. Plenum Press: New York, pp 13-22.
27. Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ (1986). Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein results in reduced neurovirulence. J Virol 59: 463-471.
28. de Souza MS, Smith AL (1991). Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM. Lab Anim Sci 41: 112-118.
29. de Souza MS, Smith AL, Bottomly K (1991). Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci 41: 99-105.
30. Dörries R, Schwender S, Imrich H, Harms H (1991). Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74: 539-545.
31. Dörries R, Imrich H, Hein A, Czub S, Schwenders (1994). The impact of the intracerebral antibody response on the clinical course of a virus-induced demyelination in a rat model system. J Neurol Neurosurg Psych 57 Suppl: 18-20.
32. Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, Dieffenbach CW (1991). Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J Virol 65: 6881-6891.
33. Dveksler GS, Dieffenbach CW, Cardellichio CB, McCuaig K, Pensiero MN, Jiang GS, Beauchemin N, Holmes KV (1993). Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J Virol 67: 1-8.
34. Erlich SS, Fleming JO, Stohlman SA, Weiner LP (1987). Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol 44: 839-842.
35. Erlich SS, Matsushima GK, Stohlman SA (1989). Studies on the mechanism of protection from acute viral encephalomyelitis by delayed-type hypersensitivity inducer T cell clones. J Neurol Sci 90: 203-216.
36. Fazakerley JK, Parker SE, Bloom F, Buchmeier MJ (1992). The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187: 178-188.
37. Fazakerley JK, Buchmeier MJ (1993). Pathogenesis of virus-induced demyelination. Adv Virus Res 42: 249-324.
38. Fleming JO, Trousdale MD, El-Zaatari FAK, Stohlman SA, Weiner LP (1986). Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58: 869-875.
39. Fleming JO, Trousdale MD, Bradbury J, Stohlman SA, Weiner LP (1987). Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb Pathogen 3: 9-20.
40. Fleming JO, Shubin RA, Sussman MA, Casteel N, and Stohlman SA (1989). Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168: 162-167.
41. Fleming JO, Wang FI, Trousdale MD, Hinton DR, Stohlman SA (1990). Immunopathogenesis of demyelination induced by MHV-4. In: Cavanagh D, Brown TDK (eds.) Coronaviruses and Their Diseases. Plenum Press: New York, pp 565-572.
42. + cells to demyelination induced by coronavirus JHM. Regional Immunol 5: 37-43.
43. Fleming JO, Houtman JJ, Alaca H, Hinze HC, McKenzie D, Aiken J, Bleasdale T, Baker S (1994). Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. In: Coronaviruses. Laude H, Vautherot JF, (eds): Plenum Press: New York, pp 227-332.
44. + T cells in vivo. Eur J Immunol 23: 1757-1761.
45. Frana MF, Behnke JN, Sturman LS, Holmes KV (1985). Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J Virol 56: 912-920.
46. Fujinami RS, Oldstone MBA (1985). Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 230: 1043-1045.
47. Gagneten S, Gout O, Dubois-Dalcq M, Rottier P, Rossen J, Holmes KV (1995). Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein. J Virol 69: 889-895.
48. Gallagher TM, Buchmeier MJ, Perlman S (1992). Cell receptor-independent infection by a neurotropic murine coronavirus. Virology 191: 517-522.
49. Gilmore W, Fleming J, Moloney M, Pan E, Richardson D (1990). Reduced expression of MHC class II molecules in a murine oligodendroglioma persistently infected with the murine coronavirus JHMV. J Cell Biochem Suppl. 14F: 100.
50. Gilmore W, Correale J, Weiner LP (1994). Coronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specific. J Exp Med 180: 1013-1023.
51. Godfraind C, Langreth SG, Cardellichio CB, Knobler R, Coutelier JP, Dubois-Dalcq M, Holmes KV (1995). Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab Invest 73: 615-627.
52. Gombold JL, Weiss SR (1992). Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathogen 13: 493-505.
53. + T cells. Microb Pathogen 18: 211-221.
54. Griot C, Bürge T, Vandevelde M, Peterhans E (1989). Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: A mechanism for bystander demyelination. Acta Neuropathol 78: 396-403.
55. + T lymphocytes from the central nervous system of rats with coronavirus JHM induced demyelinating encephalomyelitis. J Neurovirol 1: 340-348.
56. Holmes KV, Williams RK, Stephensen CB (1989). Coronavirus receptors. In: Notkins AL, Oldstone MBA (eds). Concepts in Viral Pathogenesis III. Springer-Verlag: New York. pp 106-113.
57. Holmes KV (1990). Coronaviridae and their replication. In: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B, (eds.), Virology, Second Edition. Raven Press Ltd: New York. pp 841-856.
58. Houtman JJ, Fleming JO (1996). Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 2: 101-110.
59. Jacobsen G, Perlman S (1990). Localization of virus and antibody response in mice infected persistently with MHV-JHM. In: Cavanagh D, Brown TDK (eds). Coronaviruses and Their Diseases. Plenum Press: New York. pp 573-578.
60. Joseph J, Knobler RL, Lublin FD, Hart MN (1990). Regulation of MHC Class I and II antigens on cerebral endothelial cells and astrocytes following MHV-4 infection. In: Cavanagh D, Brown TDK (eds). Coronaviruses and Their Diseases. Plenum Press: New York. pp 579-591.
61. Joseph J, Knobler RL, Lublin FD, Hart MN (1991). Mouse hepatitis virus (MHV-4, JHM) blocks γ-interferon-induced major histocompatibility complex class II antigen expression on murine cerebral endothelial cells. J Neuroimmunol 33: 181-190.
62. Joseph J, Grun JL, Lublin FD, Knobler RL (1993). Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). J Neuroimmunol 42: 47-52.
63. Kalicharran K, Dales S (1995a). Dephosphorylation of the nucleocapsid protein of inoculum JHMV may be essential for initiating replication. In: Talbot PJ, Levy GA (eds). Corona- and Related Viruses. Plenum Press: New York. pp 485-489.
64. Kalicharran K, Dales S (1995b). Involvement of microtubules and the microtubule-associated protein tau in trafficking of JHM virus and component within neurons. In: Talbot PJ, Levy GA (eds). Corona- and Related Viruses. Plenum Press: New York. pp 57-61.
65. Keck JG, Soe LH, Makino S, Stohlman SA, Lai MMC (1988). RNA recombination of murine Coronaviruses: Recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus 2. J Virol 62: 1989-1998.
66. Knobler RL, Dubois-Dalcq M, Haspel MV, Claysmith AP, Lampert PW, Oldstone MBA (1981a). Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J Neuroimmunol 1: 81-92.
67. Knobler RL, Haspel MV, Oldstone MBA (1981b). Mouse hepatitis virus type 4 (JHM strain)- induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. J Exp Med 153: 832-843.
68. Knobler RL, Lampert PW, Oldstone MBA (1982a). Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298: 279-298.
69. Knobler RL, Tunison LA, Lampert PW, Oldstone MBA (1982b). Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. Am J Pathol 109: 157-168.
70. Koolen MJM, Love S, Wouda W, Calafat J, Horzinek MC, Van der Zeijst BAM (1987). Induction of demyelination by a temperature-sensitive mutant of the coronavirus MHV-A49 is associated with restriction of viral replication in the brain. J Gen Virol 68: 703-714.
71. Koolen MJM, Osterhaus ADMA, Van Steenis G, Horzinek MC, Van der Zeijst BAM (1983). Temperature-sensitive mutants of mouse hepatitis strain A59: Isolation, characterization and neuropathogenic properties. Virology 125: 393-402.
72. + T cells. J Immunol 147: 2317-2323.
73. Kubo H, Yamada YK, Taguchi F (1994). Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol 68: 5403-5410.
74. Kyuwa S, Yamaguchi K, Hayami M, Hilgers J, Fujiwara K (1988). Spontaneous production of interleukin-2 and interleukin-3 by spleen cells from mice infected with mouse hepatitis virus type 4. J Virol 62: 3506-3508.
75. Kyuwa S, Stohlman SA (1990). Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Sem Virol 1: 273-280.
76. Kyuwa S, Yamaguchi K, Toyoda Y, Fujiwara K (1991). Induction of self-reactive T cells after murine coronavirus infection. J Virol 65: 1789-1795.
77. Kyuwa S, Yamaguchi K, Toyoda Y, Fujiwara K, Hilgers J (1992). Acute and late disease induced by murine coronavirus, strain JHM, in a series of recombinant inbred strains between BALB/cHeA and STS/A mice. Microb Pathogen 12: 95-104.
78. Kyuwa S, Cohen M, Nelson G, Tahara SM, Stohlman SA (1994). Modulation of cellular macromolecular synthesis by coronavirus: Implication for pathogenesis. J Virol 68: 6815-6819.
79. Lai MMC, Stohlman SA (1981). Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol 38: 661-670.
80. Lai MMC (1990). Coronavirus: Organization, replication and expression of genome. Annu Rev Microbiol 44: 303-333.
81. Lai MMC, Stohlman SA (1992). Molecular basis of neuropathogenicity of mouse hepatitis virus. In: Roos RP (ed). Molecular Neurovirology. Humana Press: New Jersey. pp 319-348.
82. Lai MMC (1995). Transcription, replication, recombination, and engineering of coronavirus genes. In: Talbot PJ, Levy GA (eds). Corona- and Related Viruses. Plenum Press: New York. pp 463-471.
83. Lamarre A, Talbot PJ (1995). Protection from lethal coronavirus infection by immunoglobulin fragments. J Immunol 154: 3975-3984.
84. La Monica N, Banner LR, Morris VL, Lai MMC (1991). Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 182: 883-888.
85. Lampert PW, Sims JK, Kniazeff AJ (1973). Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropath (Berl.) 24: 76-85.
86. Lavi E, Suzumura A, Murray EM, Silberberg DH, Weiss SR (1989). Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J Neuroimmunol 22: 107-111.
87. Lavi E, Weiss SR (1989). Coronaviruses. In: Gilden DH, Lipton HL (eds). Clinical and Molecular Aspects of Neurotropic Virus Infection. Kluwer Academic Publishers: Boston. pp 101-139.
88. Lavi E, Murray EM, Makino S, Stohlman SA, Lai MMC, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3′ portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest 62: 570-578.
89. Liuzzi GM, Riccio P, Dal Canto MC (1995). Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice. J Neuroimmunol 62: 91-102.
90. Luytjes W, Bredenbeek PJ, Noten AFH, Horzinek MC, Spaan WJM (1988). Sequence of mouse hepatitis virus A59 mRNA 2: Indications for RNA recombination between coronaviruses and influenza C virus. Virology 166: 415-422.
91. Martin JR, Nathanson N (1979). Animal models of virus-induced demyelination. Prog Neuropathol 4: 27-50.
92. Massa PT, Dörries R, ter Meulen V (1986). Viral particles induce Ia antigen expression on astrocytes. Nature 320: 543-546.
93. Massa PT, Wege H, ter Meulen V (1988). Growth pattern of various JHM coronavirus isolates in primary rat glial cell cultures correlates with differing neurotropism in vivo. Virus Res 9: 133-144.
94. Matyszak MK, Perry VH (1995). Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette Guérin. Neuroscience 64: 967-977.
95. + T cell subset that responds to viral glycoproteins. Virology 187: 443-452.
96. Morris VL, Tieszer C, Mackinnon J, Percy D (1989). Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169: 127-136.
97. Nagashima K, Wege H, Meyermann R, ter Meulen V (1978). Corona virus induced subacute demyelinating encephalomyelitis in rats: A morphological analysis. Acta Neuropathol (Berl.) 44: 63-70.
98. Nédellec P, Dveksler GS, Daniels E, Turbide C, Chow B, Basile AA, Holmes KV, Beauchemin N (1994). Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J Virol 68: 4525-4537.
99. Oleszak EL, Knisley K, Rodkey LS, Leibowitz JL (1992a). Microheterogeneity of S-glycoprotein of mouse hepatitis virus temperature-sensitive mutants. J Virol Meth 38: 103-112.
100. Oleszak EL, Perlman S, Leibowitz JL (1992b). MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity. Virology 186: 122-132.
101. Oleszak EL, Kuzman J, Hogue B, Parr R, Collisson EW, Rodkey LS, Leibowitz JL (1995). Molecular mimicry between Fc receptor and S peplomer protein of mouse hepatitis virus, bovine corona virus, and transmissible gastroenteritis virus. Hybridoma 14: 1-8.
102. Pappenheimer AM (1958). Pathology of infection with the JHM virus. J Natl Can Inst 20: 879-891.
103. Parker SE, Gallagher TM, Buchmeier MJ (1989). Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173: 664-673.
104. Pasick JMM, Dales S (1991). Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages. J Virol 65: 5013-5028.
105. Pasick JMM, Wilson GAR, Morris VL, Dales S (1992). SJL/J resistance to mouse hepatitis virus-JHM-induced neurologic disease can be partially overcome by viral variants of S and host immunosuppression. Microb Pathogen 13: 1-15.
106. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ (1995). Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 68: 5483-5495.
107. Perlman S, Reis D (1987). The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathogen 3, 309-314.
108. Perlman S, Schelper R, Bolger E, Ries D (1987). Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathogen 2: 185-194.
109. Perlman S, Evans G, Afifi A (1990a). Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 172: 1127-1132.
110. Perlman S, Jacobsen G, Olson AL, Afifi A (1990b). Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175: 418-426.
111. Pickel K, Müller MA, ter Meulen V (1985). Influence of maternal immunity on the outcome of murine coronavirus JHM infection in suckling mice. Med Microbiol Immunol 174: 15-24.
112. Robb JA, Bond CW, Leibowitz JL (1979). Pathogenic murine coronaviruses III. Biological and biochemical characterization of temperature-sensitive mutants of JHMV. Virology 94: 385-399.
113. Schwender A, Hein A, Imrich H, Dörries R (1994). On the role of different lymphocyte subpopulations in the course of coronavirus MHV IV (JHM)-induced encephalitis in Lewis rats. In: Laude H, Vautherot JF (eds). Coronaviruses. Plenum Press: New York. pp 425-430.
114. Schwender S, Imrich H, Dörries R (1991). The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74: 533-538.
115. Sedgwick JD, Schwender S, Imrich H, Dörries R, Butcher GW, ter Meulen V (1991). Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88: 7438-7442.
116. Selmaj KW, Raine CS (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346.
117. + cytotoxic T-lymphocyte clone. J Virol 68: 7540-7545.
118. Shubin RA, Weiner LP (1989). Viruses and demyelination. In: Kim SU (ed). Myelination and Demyelination. Implications for Multiple Sclerosis. Plenum Press: New York. pp 129-143
119. Siddell S, Wege H, ter Meulen V (1982). The structure and replication of coronaviruses. Curr Top Microbiol Immunol 99: 131-163.
120. Smith AL, Barthold SW, de Souza MS, Bottomly K (1991a). The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol 121: 89-100.
121. Smith AL, Winograd DF, de Souza MS (1991b). In vitro splenic T cell responses of diverse mouse genotypes after oronasal exposure to mouse hepatitis virus, strain JHM. Lab Anim Sci 41: 106-111.
122. Smith MS, Click RE, Plagemann PGW (1984). Control of mouse hepatitis virus replication in macrophages by a recessive gene on chromosome 7. J Immunol 133: 428-432.
123. Sorensen O, Dugre R, Percy D, Dales S (1982). In vivo and in vitro models of demyelinating disease: Endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect Immun 37: 1248-1260.
124. Sorensen O, Coulter-Mackie MB, Puchalski S, Dales S (1984). In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases. Virology 137: 347-357.
125. Sorensen O, Dales S (1985). In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy. J Virol 56: 434-438.
126. Sorenson O, Beushausen S, Coulter-Mackie M, Adler R, Dales S (1987a). In vivo and in vitro models of demyelinating disease. Factors influencing the disease process caused by coronavirus infection of rats. In: Kurstak E, Lipowski ZJ, Morozov PV (eds). Viruses, Immunity, and Mental Disorders. Plenum Publishing Corp: New York. pp 199-210.
127. Sorensen O, Saravani A, Dales S (1987b). In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus. Microb Pathogen 2: 79-90.
128. Spaan W, Cavanagh D, Horzinek MC (1988). Coronaviruses: Structure and genome expression. J Gen Virol 69: 2939-2952.
129. Stauber R, Pfleiderer M, Siddell S (1994). Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for its fusion activity. In: Laude H, Vautherot JF (eds). Coronaviruses. Plenum Press: New York. pp 165-170.
130. Stohlman SA, Frelinger JA (1978). Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. I. Genetic analysis. Immunogenetics 6: 277-281.
131. Stohlman SA, Frelinger JA, Weiner LP (1980). Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection. J Immunol 124: 1733-1739.
132. Stohlman SA, Weiner LP (1981). Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31: 38-44.
133. Stohlman SA, Brayton PR, Fleming JD, Weiner LP, Lai MMC (1982a). Murine Coronaviruses: Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol 63: 265-275
134. Stohlman SA, Woodward JG, Frelinger JA (1982b). Macrophage antiviral activity: Extrinsic versus intrinsic activity. Infect Immun 36: 672-677.
135. Stohlman SA, Brayton PR, Harmon RC, Stevenson D, Ganges RG, Matsushima GK (1983). Natural killer cell activity during mouse hepatitis virus infection: Response in the absence of interferon. Int J Cancer 31: 309-314.
136. Stohlman SA, Matsushima GK, Casteel N, Weiner LP (1986). In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. JImmunol 136: 3052-3056.
137. Stohlman SA, Sussman MA, Matsushima GK, Shubin R, Erlich SS (1988). Delayed-type hypersensitivity response in the central nervous system during JHM virus infection requires viral specificity for protection. J Neuroimmunol 19: 255-268.
138. d restricted and specific for the carboxy terminus. Virology 189: 217-224.
139. Stohlman SA, Kyuwa S, Polo JM, Brady D, Lai MMC, Bergmann CC (1993). Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol 67: 7050-7059.
140. Stohlman S, Bergmann C, La Monica N, Lai M, Yeh J, Kyuwa S (1994). JHM virus-specific cytotoxic T cells derived from the central nervous system. In: Laude H, Vautherot JF (eds). Coronaviruses. Plenum Press: New York. pp 419-423.
141. Stohlman SA, Bergmann CC, van der Veen RC, Hinton DR (1995a). Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol 69: 684-694.
142. Stohlman SA, Hinton DR, Cua D, Dimacali E, Sensintaffar J, Hofrnan FM, Tahara SM, Yao Q (1995b). Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J Virol 69: 5898-5903.
143. Sturman LS, Ricard CS, Holmes KV (1985). Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol 56: 904-911.
144. Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S (1995). Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213: 482-493.
145. Sun N, Perlman S (1995). Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J Virol 69: 633-641.
146. Sussman MA, Shubin RA, Kyuwa S, Stohlman SA (1989). T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 63: 3051-3056.
147. Suzumura A, Lavi E, Weiss SR, Silberberg D (1986). Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232: 991-993.
148. Suzumura A, Lavi E, Bhat S, Murasko D, Weiss SR, Silberberg DH (1988). Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. J Immunol 140: 2068-2072.
149. Taguchi F, Siddell SG, Wege H, ter Meulen V (1985). Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J Virol 54: 429-435.
150. Taguchi F (1993). Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol 67: 1195-1202.
151. Taguchi F (1995). The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol 69: 7260-7263.
152. Taguchi F, Kubo H, Takahashi H, Suzuki H (1995). Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV. Virology 208: 67-74.
153. Talbot PJ, Knobler RL, Buchmeier MJ (1987). Importance of the antibody response in the outcome of virus-induced diseases of the central nervous system. Antibody modulation of coronavirus encephalitis in a mouse model. In: Kurstak E, Lipowski ZJ, Morozov PV (eds). Viruses, Immunity, and Mental Disorders. Plenum Publishing Corp: New York. pp 211-220.
154. Theil V, Siddell S (1995). Translation of the MHV sM protein is mediated by the internal entry of ribosomes on mRNA 5. In: Talbot PJ, Levy GA (eds). Corona-and Related Viruses. Plenum Press: New York. pp 311-315.
155. Vlasak R, Luytjes W, Leider J, Spaan W, Palese P (1988). The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol 62: 4686-4690.
156. Wang FI, Stohlman SA, Fleming JO (1990). Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 30: 31-41.
157. Wang FI, Fleming JO, Lai MMC (1992a). Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology 186: 742-749.
158. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO (1992b). Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 6: 744-754.
159. Watanabe R, Wege H, ter Meulen V (1983). Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalitis. Nature 305: 150-153.
160. Watanabe R, Wege H, ter Meulen V (1987). Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats. Lab Invest 57: 375-384.
161. Wege H, Siddell S, ter Meulen V (1982). The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol 99: 165-200.
162. Wege H, Dörries R, Wege H (1984a). Hybridoma antibodies to the murine coronavirus JHM: Characterization of epitopes on the peplomer protein (E2). J Gen Virol 65: 1931-1942.
163. Wege H, Watanabe R, ter Meulen V (1984b). Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol 6: 325-336.
164. Wege H, Winter J, Meyermann R (1988). The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: Definition of critical
165. + T cell site on the nucleocapsid protein of murine coronavirus contributes to protection against encephalomyelitis. J Gen Virol 74: 1287-1294.
166. Weiner LP (1973). Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 28: 298-303.
167. Weiner LP (1987). Coronaviruses: A historical perspective. In: Lai MMC, Stohlman SA (eds). Coronaviruses. Plenum Press: New York. pp 1 -5.
168. Weiss SR, Leibowitz JL (1981). Comparison of the RNAs of murine and human coronaviruses. In: ter Meulen V, Siddell S, Wege H (eds). Biochemistry and Biology of Coronaviruses. Plenum Press: New York. pp 245-259.
169. Williams RK, Jiang GS, Holmes KV (1991). Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA 88: 5533-5536.
170. + T cells. J Virol 64: 4589-4592.
171. Williamson JSP, Sykes KC, Stohlman SA (1991). Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol 32: 199-207.
172. Williamson JSP (1992). Virus-specific T cells in the central nervous system following infection with an avirulent neurotropic mouse hepatitis virus. Regional Immunol 4: 145-152.
173. Wisniewski HM, Bloom BR (1975). Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction. J Exp Med 141: 346-359.
174. Wisniewski HM (1977). Immunopathology of demyelination in autoimmune diseases and virus infections. Br Med Bull 33: 54-59.
175. Wucherpfennig KW, Strominger JL (1995). Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
176. Yamaguchi K, Goto N, Kyuwa S, Hayami M, Toyoda Y (1991). Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol 32: 1-9.
177. Yokomori K, Banner LR, Lai MMC (1991). Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology 183: 647-657.
178. Yokomori K, Baker SC, Stohlman SA, Lai MMC (1992). Hemagglutinin-esterase-specific monoclonal antibodies alter the neuropathogenicity of mouse hepatitis virus. J Virol 66: 2865-2874.
179. Yokomori K, Lai MMC (1992a). Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol 66: 6194-6199.
180. Yokomori K, Lai MMC (1992b). The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: Implications for the requirement of a second factor for viral infection. J Virol 66: 6931-6938.
181. Yokomori K, Asanaka M, Stohlman SA, Lai MMC (1993a). A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology 196: 45-56.
182. Yokomori K, Stohlman SA, Lai MMC (1993b). The detection and characterization of multiple hemagglutinin-esterase (HE)-defective viruses in the mouse brain during subacute demyelination induced by mouse hepatitis virus. Virology 192: 170-178.
183. Yokomori K, Asanaka M, Stohlman SA, Makino S, Shubin RA, Gilmore W, Weiner LP, Wang FI, Lai MMC (1995). Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol 1: 330-339.
184. Yu X, Bi W, Weiss SR, Leibowitz JL (1994). Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology 202: 1018-1023.
185. Zimmer MJ, Dales S (1989). In vivo and in vitro models of demyelinating diseases XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus. Microb Pathogen 6: 7-16.
186. Zimprich F, Winter J, Wege H, Lassman H (1991). Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response. Neuropath Appl Neurobiol 17: 469-484.